ESCHERICHIA COLI STRAIN MARKET ANALYSIS

Escherichia Coli Strain Market, By Strain Type (Commensal strains, Diarrheal strains, Extraintestinal pathogenic strains, Uropathogenic strains, Neonatal meningitis strains, and Others), By Application (Diagnostics, Research, Therapeutics, Production of recombinant proteins, Quality control organisms, and Others), By Pathogenicity (Pathogenic E. coli and Non-pathogenic E. coli), By End User (Research Institutes, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Escherichia Coli Strain Market Regional Insights

North America is expected to dominate the market with a market share of 33.1% in 2023. This is due to the increasing awareness of foodborne illnesses and the rising demand for efficient diagnostic methods in the region.
Europe is the second-largest market for escherichia coli strain, with a market share of 27.2% in 2023. This is due to the well-established healthcare infrastructure and the increasing government initiatives to improve food safety in the region.
Asia Pacific is expected to be the fastest-growing market for escherichia coli strain, with a CAGR of 7.4% from 2023 to 2030. This is due to the growing population, increasing urbanization, and the rising demand for food safety in the region.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East